Skip to Main content Skip to Navigation
Conference papers

OA04-01. Safety and immunogenicity of LIPO-5, a HIV-1 lipopeptide vaccine: results of ANRS VAC18, a phase 2, randomized, double-blind, placebo-controlled trial

Résumé : n.a
Document type :
Conference papers
Complete list of metadatas

https://www.hal.inserm.fr/inserm-00663582
Contributor : Ed. Bmc <>
Submitted on : Friday, January 27, 2012 - 1:19:34 PM
Last modification on : Wednesday, September 16, 2020 - 4:56:50 PM
Long-term archiving on: : Saturday, April 28, 2012 - 2:26:33 AM

Files

Identifiers

Collections

Citation

Dominique Salmon-Céron, Christine Durier, Corinne Desaint, Lise Cuzin, Mathieu Surenaud, et al.. OA04-01. Safety and immunogenicity of LIPO-5, a HIV-1 lipopeptide vaccine: results of ANRS VAC18, a phase 2, randomized, double-blind, placebo-controlled trial. AIDS Vaccine 2009, Oct 2009, Paris, France. pp.O25, ⟨10.1186/1742-4690-6-S3-O25⟩. ⟨inserm-00663582⟩

Share

Metrics

Record views

570

Files downloads

884